HomePress ReleaseCabbacis Licenses Low-Nicotine Tobacco From NCSU

Cabbacis Licenses Low-Nicotine Tobacco From NCSU

NIAGARA FALLS, N.Y.–(BUSINESS WIRE)–Cabbacis (the “Company”), a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on harm reduction products, announced today that it has licensed a flue-cured, low-nicotine tobacco line from North Carolina State University (NCSU).

The novel tobacco line was produced by utilizing naturally-occurring mutations in tobacco genes. No genetic engineering or genetic modifications were utilized which greatly facilitates the international planting of this low-nicotine tobacco. Also, commercial products made from this tobacco line, which was produced from traditional plant breeding techniques, will have marketing and consumer acceptance advantages over genetically-engineered, low-nicotine counterparts.

Patents have been filed on this proprietary low-nicotine tobacco line which has been grown in field trials conducted by NCSU. On average, it contains about ninety-five percent (95%) less nicotine than conventional flue-cured tobacco used in commercial cigarette brands. Cabbacis is currently growing this low-nicotine tobacco on several acres.

Mr. Pandolfino, the Company’s CEO stated, “I am quite pleased that Cabbacis has obtained formal rights to this novel, low-nicotine tobacco line. I’ve had licensing relationships through various companies with NCSU since 1998, and I look forward to another mutually beneficial relationship with the university.”

RELATED:  Indiva Announces Commencement of Court-Approved Sale Process

In addition to an upfront license fee, Cabbacis will also pay NCSU annual license fees, running royalties on sales and milestone payments. The Company will also cover patent expenses and any expenses related to filing plant variety right (PVR) applications.

About Cabbacis

Cabbacis is committed to developing and commercializing reduced-nicotine cigarettes and vaporizer pods. Both types of products in development are comprised predominately of tobacco and include hemp. The Company stands ready to also move forward with reduced-nicotine tobacco cigarettes without hemp.

Reduced-nicotine cigarettes without hemp that contain about 95 percent less nicotine than conventional cigarettes have been evaluated in dozens of independent studies. Results demonstrate that subjects smoked fewer cigarettes per day, reduced their nicotine dependence and exposure, doubled their quit attempts, and/or increased their number of smoke-free days. The Company believes including hemp flower in reduced-nicotine cigarettes improves taste and sensory characteristics and will improve effectiveness.

RELATED:  World’s First: California State Fair Expands Cannabis Competition, Hosting Onsite Sales and Consumption Presented by Embarc

The Company’s worldwide patent portfolio includes 32 issued patents and various pending patent applications across the United States, Europe, China, India, Japan, Indonesia, Russia, South Korea, Canada, Australia, New Zealand, Mexico, Brazil and other countries — where approximately two-thirds of the world’s smokers reside. The Company holds 6 U.S. patents. Cabbacis Inc wholly owns Cabbacis LLC.

To learn more about Cabbacis, please visit www.cabbacis.com.

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the federal securities law. All statements other than statements of historical or current facts made in this document are forward-looking. We identify forward-looking statements in this document by using words or phrases such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “foresee,” “intend,” “likely,” “may,” “objective,” “potential,” “plan,” “predict,” “project,” “seek,” “should,” “will” and similar words or phrases and their negatives. Forward-looking statements reflect our current expectations and are inherently uncertain. Actual outcomes or results could differ materially for a variety of reasons. Factors that could cause actual results to differ materially are described in “Risk Factors” in our Regulation A Offering Circular filed with the SEC and in our Annual Report on Form 1-K for the period ended December 31, 2023 filed with the SEC. We undertake no responsibility to publicly update or revise any forward-looking statement except as required by applicable law.

RELATED:  Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Company’s securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that state or jurisdiction.

Contacts

Media

Tracy Witman

support@cabbacis.com



Keep exploring...

Related Articles

Luxury Cannabis Cigar Brand Launches Hand-Rolled Cannagar in New York Market

Colorado-Based Cannabis Brand, Made in Xiaolin, Expands Product Offerings to New York, Returns to...

Epilepsy Drugs Market, Size, Global Research 2024-2030 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott Laboratories, Alkem Laboratories, Bausch, GSK, Novartis, and Pfizer –...

DUBLIN--(BUSINESS WIRE)--The "Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight,...

NJOY Receives First FDA Authorizations for Menthol E-Vapor Products

RICHMOND, Va.--(BUSINESS WIRE)--$MO--Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food...

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year

The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the...

One80 Intermediaries Offers Liability Insurance for Chief Restructuring Officers

The policy covers gaps between the distressed company’s insurance and that of their Chief...

Life Is Chill Expands Line of THC Soft Gels with New Live Resin THC Capsules, A First Of Its Kind for the Arizona Market

The new plant-based soft gel will launch on Friday, January 19, providing Arizona consumers...